These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17417639)

  • 61. Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
    Joosten SEP; Gregoricchio S; Stelloo S; Yapıcı E; Huang CF; Yavuz K; Donaldson Collier M; Morova T; Altintaş UB; Kim Y; Canisius S; Moelans CB; van Diest PJ; Korkmaz G; Lack NA; Vermeulen M; Linn SC; Zwart W
    Genome Res; 2024 May; 34(4):539-555. PubMed ID: 38719469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
    Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
    Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens.
    Takeshita T; Yamamoto Y; Yamamoto-Ibusuki M; Inao T; Sueta A; Fujiwara S; Omoto Y; Iwase H
    Transl Res; 2015 Dec; 166(6):540-553.e2. PubMed ID: 26434753
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.
    Takeshita T; Yamamoto Y; Yamamoto-Ibusuki M; Inao T; Sueta A; Fujiwara S; Omoto Y; Iwase H
    Oncotarget; 2016 May; 7(22):32504-18. PubMed ID: 27102299
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14.
    Wolmark N; Mamounas EP; Baehner FL; Butler SM; Tang G; Jamshidian F; Sing AP; Shak S; Paik S
    J Clin Oncol; 2016 Jul; 34(20):2350-8. PubMed ID: 27217450
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.
    Moelans CB; Monsuur HN; de Pinth JH; Radersma RD; de Weger RA; van Diest PJ
    Cell Oncol (Dordr); 2011 Oct; 34(5):489-94. PubMed ID: 21541733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
    Gomes-Rochette NF; Souza LS; Tommasi BO; Pedrosa DF; Eis SR; Fin ID; Vieira FL; Graceli JB; Rangel LB; Silva IV
    PLoS One; 2017; 12(2):e0169266. PubMed ID: 28199328
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.
    Choschzick M; Lebeau A; Marx AH; Tharun L; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Simon R; Sauter G; Schwarz J
    Hum Pathol; 2010 Mar; 41(3):358-65. PubMed ID: 19896697
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
    Sefrioui D; Perdrix A; Sarafan-Vasseur N; Dolfus C; Dujon A; Picquenot JM; Delacour J; Cornic M; Bohers E; Leheurteur M; Rigal O; Tennevet I; Thery JC; Alexandru C; Guillemet C; Moldovan C; Veyret C; Frebourg T; Di Fiore F; Clatot F
    Int J Cancer; 2015 Nov; 137(10):2513-9. PubMed ID: 25994408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
    Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation.
    Tomita S; Abdalla MOA; Fujiwara S; Matsumori H; Maehara K; Ohkawa Y; Iwase H; Saitoh N; Nakao M
    Nat Commun; 2015 Apr; 6():6966. PubMed ID: 25923108
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR.
    Maekawa R; Sato S; Okada M; Lee L; Tamura I; Jozaki K; Kajimura T; Asada H; Yamagata Y; Tamura H; Yamamoto S; Sugino N
    Mol Endocrinol; 2016 Mar; 30(3):335-47. PubMed ID: 26683811
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
    Fjeldheim FN; Frydenberg H; Flote VG; McTiernan A; Furberg AS; Ellison PT; Barrett ES; Wilsgaard T; Jasienska G; Ursin G; Wist EA; Thune I
    BMC Cancer; 2016 Oct; 16(1):776. PubMed ID: 27717337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The ESR1 and GPX1 gene expression level in human malignant and non-malignant breast tissues.
    Król MB; Galicki M; Grešner P; Wieczorek E; Jabłońska E; Reszka E; Morawiec Z; Wąsowicz W; Gromadzińska J
    Acta Biochim Pol; 2018; 65(1):51-57. PubMed ID: 29543921
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
    Dunning AM; Michailidou K; Kuchenbaecker KB; Thompson D; French JD; Beesley J; Healey CS; Kar S; Pooley KA; Lopez-Knowles E; Dicks E; Barrowdale D; Sinnott-Armstrong NA; Sallari RC; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Hills M; Jarosz M; Drury S; Canisius S; Bolla MK; Dennis J; Wang Q; Hopper JL; Southey MC; Broeks A; Schmidt MK; Lophatananon A; Muir K; Beckmann MW; Fasching PA; Dos-Santos-Silva I; Peto J; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; González-Neira A; Perez JI; Anton-Culver H; Eunjung L; Arndt V; Brenner H; Meindl A; Schmutzler RK; Brauch H; Hamann U; Aittomäki K; Blomqvist C; Ito H; Matsuo K; Bogdanova N; Dörk T; Lindblom A; Margolin S; Kosma VM; Mannermaa A; Tseng CC; Wu AH; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Peterlongo P; Radice P; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Goldberg MS; Teo SH; Yip CH; Nord S; Borresen-Dale AL; Kristensen V; Long J; Zheng W; Pylkäs K; Winqvist R; Andrulis IL; Knight JA; Devilee P; Seynaeve C; Figueroa J; Sherman ME; Czene K; Darabi H; Hollestelle A; van den Ouweland AM; Humphreys K; Gao YT; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Ghoussaini M; Perkins BJ; Shah M; Choi JY; Kang D; Lee SC; Hartman M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Brennan P; Sangrajrang S; Ambrosone CB; Toland AE; Shen CY; Wu PE; Orr N; Swerdlow A; McGuffog L; Healey S; Lee A; Kapuscinski M; John EM; Terry MB; Daly MB; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Neuhausen SL; Ejlertsen B; Hansen TV; Osorio A; Benitez J; Rando R; Weitzel JN; Bonanni B; Peissel B; Manoukian S; Papi L; Ottini L; Konstantopoulou I; Apostolou P; Garber J; Rashid MU; Frost D; ; Izatt L; Ellis S; Godwin AK; Arnold N; Niederacher D; Rhiem K; Bogdanova-Markov N; Sagne C; Stoppa-Lyonnet D; Damiola F; ; Sinilnikova OM; Mazoyer S; Isaacs C; Claes KB; De Leeneer K; de la Hoya M; Caldes T; Nevanlinna H; Khan S; Mensenkamp AR; ; Hooning MJ; Rookus MA; Kwong A; Olah E; Diez O; Brunet J; Pujana MA; Gronwald J; Huzarski T; Barkardottir RB; Laframboise R; Soucy P; Montagna M; Agata S; Teixeira MR; ; Park SK; Lindor N; Couch FJ; Tischkowitz M; Foretova L; Vijai J; Offit K; Singer CF; Rappaport C; Phelan CM; Greene MH; Mai PL; Rennert G; Imyanitov EN; Hulick PJ; Phillips KA; Piedmonte M; Mulligan AM; Glendon G; Bojesen A; Thomassen M; Caligo MA; Yoon SY; Friedman E; Laitman Y; Borg A; von Wachenfeldt A; Ehrencrona H; Rantala J; Olopade OI; Ganz PA; Nussbaum RL; Gayther SA; Nathanson KL; Domchek SM; Arun BK; Mitchell G; Karlan BY; Lester J; Maskarinec G; Woolcott C; Scott C; Stone J; Apicella C; Tamimi R; Luben R; Khaw KT; Helland Å; Haakensen V; Dowsett M; Pharoah PD; Simard J; Hall P; García-Closas M; Vachon C; Chenevix-Trench G; Antoniou AC; Easton DF; Edwards SL
    Nat Genet; 2016 Apr; 48(4):374-86. PubMed ID: 26928228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Currently Applied Molecular Assays for Identifying
    Lee N; Park MJ; Song W; Jeon K; Jeong S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233830
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ESR1 inhibits ionizing radiation-induced ferroptosis in breast cancer cells via the NEDD4L/CD71 pathway.
    Liu L; Zhang C; Qu S; Liu R; Chen H; Liang Z; Tian Z; Li L; Ma S; Liu X
    Arch Biochem Biophys; 2022 Aug; 725():109299. PubMed ID: 35613689
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ESR1 mutations in breast cancer.
    Clatot F; Augusto L; Di Fiore F
    Aging (Albany NY); 2017 Jan; 9(1):3-4. PubMed ID: 28130553
    [No Abstract]   [Full Text] [Related]  

  • 80. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.
    Li S; Shen D; Shao J; Crowder R; Liu W; Prat A; He X; Liu S; Hoog J; Lu C; Ding L; Griffith OL; Miller C; Larson D; Fulton RS; Harrison M; Mooney T; McMichael JF; Luo J; Tao Y; Goncalves R; Schlosberg C; Hiken JF; Saied L; Sanchez C; Giuntoli T; Bumb C; Cooper C; Kitchens RT; Lin A; Phommaly C; Davies SR; Zhang J; Kavuri MS; McEachern D; Dong YY; Ma C; Pluard T; Naughton M; Bose R; Suresh R; McDowell R; Michel L; Aft R; Gillanders W; DeSchryver K; Wilson RK; Wang S; Mills GB; Gonzalez-Angulo A; Edwards JR; Maher C; Perou CM; Mardis ER; Ellis MJ
    Cell Rep; 2013 Sep; 4(6):1116-30. PubMed ID: 24055055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.